IWQOL-Lite-CT
The pivotal Phase 3 trials and post-approval cardiovascular, kidney, and sleep-apnea outcome studies.
Definition
The Impact of Weight on Quality of Life-Lite Clinical Trials version — a 20-item patient-reported outcome questionnaire validated for use in obesity drug trials. Scored 0-100, higher is better; physical-function and psychosocial subdomains are reported separately. Clinically meaningful improvement threshold is ~14.6 points. STEP-1 and SURMOUNT-1 both reported large IWQOL-Lite-CT gains, used by FDA in evaluating quality-of-life claims for Wegovy and Zepbound labeling.
STEP-1 quality-of-life endpoint →
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
Related terms in Major trials
Looking for more depth?
- STEP-1 quality-of-life endpoint
- Browse the full GLP-1 glossary (71 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers